![](/img/cover-not-exists.png)
BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia
Pierceall, W. E., Kornblau, S. M., Carlson, N. E., Huang, X., Blake, N., Lena, R., Elashoff, M., Konopleva, M., Cardone, M. H., Andreeff, M.Volume:
12
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-13-0692
Date:
December, 2013
File:
PDF, 651 KB
english, 2013